Rowley D A, Fitch F W, Mosier D E, Solliday S, Coppleson L W, Brown B W
J Exp Med. 1968 May 1;127(5):983-1002. doi: 10.1084/jem.127.5.983.
Mitotic blocking agents, colchicine or Velban, were used to estimate cycle times of spleen cells which release hemolysin for sheep erythrocytes (plaque-forming cells). The cells were obtained either from rats immunized with sheep erythrocytes or from cultures of mouse spleen cells immunized in vitro with the same antigen. 2, 3, or 4 days after immunization, animals or cell cultures were treated with mitotic blocking agents for periods of time ranging from 2.5 to 7 hr; plaque-forming cells were then enumerated. Decreased numbers of plaque-forming cells were found after such treatment. The extent of reduction was a function of duration of the drug treatment and the method of immunization, but was independent of the time after immunization. The evidence presented is consistent with premises that: (a) plaque-forming cells in mitosis do not release sufficient antibody to be detected, (b) mitotic blocking agents, by arresting plaque-forming cells in metaphase, prevent not only detection of these cells but also the increase in number of plaque-forming cells which would have resulted from cell division, (c) mitotic blocking agents do not affect release of antibody by cells in interphase. Cell cycle times, based on the extent of reduction of plaque-forming cells per unit time of drug treatment, were estimated using a mathematical model appropriate for an exponentially increasing population of cells. Cell cycle times estimated using the mitotic blocking agents agreed well with cell doubling times calculated from the increase in plaque-forming cells occurring 1-4 days after immunization. Increased responses produced by higher antigen doses or treatment of immunized animals with an adjuvant resulted from an increased rate of division of responding cells and their progeny. The results are consistent with a cell selection theory of antibody formation. Antigenic stimulation causes relatively few cells to proliferate and to synthesize antibody; apparently the magnitude of the response is dependent primarily on the rate of division of responding cells. It is suggested on the basis of observations of in vitro-immunized cell cultures that the rate of division of responding cells may be dependent on the rate of interaction between two cell types, both of which are essential for the in vitro plaque-forming cell response.
有丝分裂阻断剂秋水仙碱或长春花碱被用于估算脾细胞的周期时间,这些脾细胞能释放针对绵羊红细胞的溶血素(即形成噬斑细胞)。细胞要么取自用绵羊红细胞免疫过的大鼠,要么取自体外经相同抗原免疫的小鼠脾细胞培养物。免疫后2、3或4天,对动物或细胞培养物用有丝分裂阻断剂处理2.5至7小时;然后对形成噬斑细胞进行计数。经此类处理后,发现形成噬斑细胞的数量减少。减少的程度是药物处理持续时间和免疫方法的函数,但与免疫后的时间无关。所提供的证据与以下前提一致:(a) 处于有丝分裂期的形成噬斑细胞释放的抗体不足以被检测到;(b) 有丝分裂阻断剂通过使形成噬斑细胞停滞在中期,不仅阻止了这些细胞的检测,还阻止了因细胞分裂而导致的形成噬斑细胞数量的增加;(c) 有丝分裂阻断剂不影响间期细胞的抗体释放。基于药物处理单位时间内形成噬斑细胞减少的程度,使用适合指数增长细胞群体的数学模型估算细胞周期时间。用有丝分裂阻断剂估算的细胞周期时间与根据免疫后1 - 4天形成噬斑细胞增加情况计算出的细胞倍增时间非常吻合。更高抗原剂量或用佐剂处理免疫动物所产生的增强反应,是由反应细胞及其后代的分裂速率增加所致。这些结果与抗体形成的细胞选择理论一致。抗原刺激使相对较少的细胞增殖并合成抗体;显然,反应的强度主要取决于反应细胞的分裂速率。基于对体外免疫细胞培养物的观察表明,反应细胞的分裂速率可能取决于两种细胞类型之间的相互作用速率,这两种细胞类型对于体外形成噬斑细胞反应都是必不可少的。